B. Metzler Seel. Sohn & Co. Holding Ag Elanco Animal Health Inc Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Elanco Animal Health Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 38,922 shares of ELAN stock, worth $555,416. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,922
Previous 6,981
457.54%
Holding current value
$555,416
Previous $223,000
256296.41%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELAN
# of Institutions
441Shares Held
484MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.19 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$750 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$706 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$401 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$333 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.77B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...